USTEKINUMAB
Manner of administration:Injection
Restriction
Indication: Severe Crohn disease
Treatment phase: Initial treatment - Initial 1 (new patient)
Restriction
Indication: Severe Crohn disease
Treatment phase: Initial treatment - Initial 2 (change or recommencement of treatment after a break
in biological medicine of less than 5 years)
Restriction
Indication: Severe Crohn disease
Treatment phase: Initial treatment - Initial 3 (recommencement of treatment after a break in biological
medicine of more than 5 years)
Manner of administration:Injection
Restriction
Indication: Severe Crohn disease
Treatment phase: Initial treatment - Initial 1 (new patient)
Restriction
Indication: Severe Crohn disease
Treatment phase: Initial treatment - Initial 2 (change or recommencement of treatment after a break
in biological medicine of less than 5 years)
Restriction
Indication: Severe Crohn disease
Treatment phase: Initial treatment - Initial 3 (recommencement of treatment after a break in biological
medicine of more than 5 years)
Manner of administration:Injection
Restriction
Indication: Moderate to severe ulcerative colitis
Treatment phase: Initial treatment - Initial 1 (new patient)
Restriction
Indication: Moderate to severe ulcerative colitis
Treatment phase: Initial treatment - Initial 2 (change or recommencement of treatment after a break
in biological medicine of less than 5 years)
Restriction
Indication: Moderate to severe ulcerative colitis
Treatment phase: Initial treatment - Initial 3 (recommencement of treatment after a break in biological
medicine of more than 5 years)
Manner of administration:Injection
Restriction
Indication: Moderate to severe ulcerative colitis
Treatment phase: Initial treatment - Initial 1 (new patient)
Restriction
Indication: Moderate to severe ulcerative colitis
Treatment phase: Initial treatment - Initial 2 (change or recommencement of treatment after a break
in biological medicine of less than 5 years)
Restriction
Indication: Moderate to severe ulcerative colitis
Treatment phase: Initial treatment - Initial 3 (recommencement of treatment after a break in biological
medicine of more than 5 years)
Manner of administration:Injection
Restriction
Indication: Complex refractory Fistulising Crohn disease
Treatment phase: Initial treatment - Initial 1 (new patient or recommencement of treatment after a
break in biological medicine of more than 5 years)
Restriction
Indication: Complex refractory Fistulising Crohn disease
Treatment phase: Initial treatment - Initial 2 (change or recommencement of treatment after a break
in biological medicine of less than 5 years)
Restriction
Indication: Complex refractory Fistulising Crohn disease
Treatment phase: Initial 1 (new patient or recommencement of treatment after a break in biological
medicine of more than 5 years), Initial 2 (change or recommencement of treatment after
a break in biological medicine of less than 5 years) - balance of supply
Manner of administration:Injection
Restriction
Indication: Complex refractory Fistulising Crohn disease
Treatment phase: Initial treatment - Initial 1 (new patient or recommencement of treatment after a
break in biological medicine of more than 5 years)
Restriction
Indication: Complex refractory Fistulising Crohn disease
Treatment phase: Initial treatment - Initial 2 (change or recommencement of treatment after a break
in biological medicine of less than 5 years)
Restriction
Indication: Complex refractory Fistulising Crohn disease
Treatment phase: Initial 1 (new patient or recommencement of treatment after a break in biological
medicine of more than 5 years), Initial 2 (change or recommencement of treatment after
a break in biological medicine of less than 5 years) - balance of supply